1.
TPC3: COST OF AML TREATMENT IN BELGIUM: RESULTS OF A RANDOMIZED TRIAL WITH AND WITHOUT FILGRASTIM USE
Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in Belgium
2.
3.
Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society
Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).
Supplementary Material for: Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium ....
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
Myelofibrosis patients in Belgium : disease characteristics
